Yongjuan Li

2.4k total citations
45 papers, 1.7k citations indexed

About

Yongjuan Li is a scholar working on Biomedical Engineering, Molecular Biology and Social Psychology. According to data from OpenAlex, Yongjuan Li has authored 45 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Biomedical Engineering, 16 papers in Molecular Biology and 10 papers in Social Psychology. Recurrent topics in Yongjuan Li's work include Nanoplatforms for cancer theranostics (17 papers), Nanoparticle-Based Drug Delivery (8 papers) and RNA Interference and Gene Delivery (7 papers). Yongjuan Li is often cited by papers focused on Nanoplatforms for cancer theranostics (17 papers), Nanoparticle-Based Drug Delivery (8 papers) and RNA Interference and Gene Delivery (7 papers). Yongjuan Li collaborates with scholars based in China, United States and Singapore. Yongjuan Li's co-authors include Lichen Yin, Juanjuan Dang, Qiujun Liang, Hua He, Shixian Lv, Jianjun Cheng, Feng Li, Yu‐Chen Wu, Pixu Li and Xiangyong Gu and has published in prestigious journals such as Journal of the American Chemical Society, Advanced Materials and Nature Communications.

In The Last Decade

Yongjuan Li

44 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yongjuan Li China 23 628 495 389 325 224 45 1.7k
Patrick Müller Germany 27 578 0.9× 437 0.9× 78 0.2× 311 1.0× 283 1.3× 72 2.3k
Haiying Wei China 25 447 0.7× 224 0.5× 345 0.9× 512 1.6× 257 1.1× 114 2.6k
Cheng Wang China 22 222 0.4× 167 0.3× 90 0.2× 97 0.3× 21 0.1× 130 1.8k
Rajesh K. Jain India 17 650 1.0× 195 0.4× 546 1.4× 133 0.4× 79 0.4× 46 1.6k
Yulin Wang China 24 195 0.3× 396 0.8× 85 0.2× 236 0.7× 113 0.5× 166 2.3k
Yue Pan United States 24 247 0.4× 355 0.7× 238 0.6× 168 0.5× 24 0.1× 118 1.8k
Hun Lee South Korea 34 685 1.1× 243 0.5× 81 0.2× 121 0.4× 15 0.1× 197 4.6k
Emanuela Mari Italy 25 112 0.2× 245 0.5× 26 0.1× 84 0.3× 158 0.7× 66 1.4k
Seulki Lee South Korea 15 709 1.1× 285 0.6× 464 1.2× 451 1.4× 108 0.5× 43 1.6k

Countries citing papers authored by Yongjuan Li

Since Specialization
Citations

This map shows the geographic impact of Yongjuan Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yongjuan Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yongjuan Li more than expected).

Fields of papers citing papers by Yongjuan Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yongjuan Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yongjuan Li. The network helps show where Yongjuan Li may publish in the future.

Co-authorship network of co-authors of Yongjuan Li

This figure shows the co-authorship network connecting the top 25 collaborators of Yongjuan Li. A scholar is included among the top collaborators of Yongjuan Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yongjuan Li. Yongjuan Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Yongjuan, Yichen Guo, Xinyan Li, et al.. (2025). Personalized Nanovaccine Based on STING-Activating Nanocarrier for Robust Cancer Immunotherapy. ACS Nano. 19(3). 3226–3239. 10 indexed citations
2.
Li, Yongjuan, Yayun Wang, Xiaohan Lou, et al.. (2024). A polymeric nanoplatform enhances the cGAS-STING pathway in macrophages to potentiate phagocytosis for cancer immunotherapy. Journal of Controlled Release. 373. 447–462. 14 indexed citations
3.
Li, Yongjuan, Rongrong Zhu, Yichen Guo, et al.. (2024). Sequential-gated transformable nanoprodrug potentiates antitumor immunity through TME modulation and STING activation. Chinese Chemical Letters. 36(9). 110704–110704. 2 indexed citations
4.
Yu, Guangtao, et al.. (2024). How state mindfulness affects mobile phones usage while walking: A daily diary study in China. Journal of Safety Research. 90. 216–224. 1 indexed citations
5.
Li, Yongjuan, Xinyan Li, Mengzhe Zhang, et al.. (2024). Spatiotemporal orchestration of a ferroptosis-immunotherapy “cycle” via a sequential drug delivery system for antitumor immunity. Nano Today. 59. 102535–102535. 3 indexed citations
6.
Li, Yongjuan, Mengzhe Zhang, Yichen Guo, et al.. (2024). A Triple‐Responsive Polymeric Prodrug Nanoplatform with Extracellular ROS Consumption and Intracellular H2O2 Self‐Generation for Imaging‐Guided Tumor Chemo‐Ferroptosis‐Immunotherapy. Advanced Healthcare Materials. 13(16). e2303568–e2303568. 13 indexed citations
7.
Li, Yongjuan, Yang Yang, Zhenzhen Li, et al.. (2024). Nanomedicine‐Enabled Mild Photothermal Therapy Strategies for Enhanced Antitumor Treatment. SHILAP Revista de lepidopterología. 4(3). 8 indexed citations
8.
Li, Yongjuan, Mengzhe Zhang, Rong Ma, et al.. (2024). Polymeric nanocarrier via metabolism regulation mediates immunogenic cell death with spatiotemporal orchestration for cancer immunotherapy. Nature Communications. 15(1). 8586–8586. 31 indexed citations
9.
Li, Yongjuan, et al.. (2023). Servant Leadership and Constructive Deviance: A Moderated Mediation Model. Academy of Management Proceedings. 2023(1). 1 indexed citations
10.
Li, Yongjuan, et al.. (2023). Nanotechnology connecting copper metabolism and tumor therapy. SHILAP Revista de lepidopterología. 2(2). 13 indexed citations
11.
Li, Yongjuan, et al.. (2023). Nanoparticle‐Mediated STING Activation for Cancer Immunotherapy. Advanced Healthcare Materials. 12(19). e2300260–e2300260. 43 indexed citations
12.
Li, Yongjuan, et al.. (2023). Cell Death Pathway Regulation by Functional Nanomedicines for Robust Antitumor Immunity. Advanced Science. 11(3). e2306580–e2306580. 35 indexed citations
13.
Yang, Weijing, Rongrong Zhu, Yichen Guo, et al.. (2023). Transformable prodrug nanoplatform via tumor microenvironment modulation and immune checkpoint blockade potentiates immunogenic cell death mediated cancer immunotherapy. Theranostics. 13(6). 1906–1920. 13 indexed citations
14.
Li, Yongjuan, Juanjuan Dang, Qiujun Liang, & Lichen Yin. (2019). Carbon monoxide (CO)-Strengthened cooperative bioreductive anti-tumor therapy via mitochondrial exhaustion and hypoxia induction. Biomaterials. 209. 138–151. 66 indexed citations
15.
Dang, Juanjuan, Huan Ye, Yongjuan Li, et al.. (2019). Multivalency-assisted membrane-penetrating siRNA delivery sensitizes photothermal ablation via inhibition of tumor glycolysis metabolism. Biomaterials. 223. 119463–119463. 83 indexed citations
16.
Ralston, David A., Carolyn P. Egri, Irina Naoumova, et al.. (2018). An empirical test of the trichotomy of values crossvergence theory. Asia Pacific Journal of Management. 37(1). 65–90. 11 indexed citations
17.
Li, Feng, Guangxi Wang, Yongjuan Li, & Ronggang Zhou. (2016). Job demands and driving anger: The roles of emotional exhaustion and work engagement. Accident Analysis & Prevention. 98. 198–205. 41 indexed citations
18.
Zhang, Jingyu, et al.. (2013). Task complexity matters: The influence of trait mindfulness on task and safety performance of nuclear power plant operators. Personality and Individual Differences. 55(4). 433–439. 68 indexed citations
19.
Li, Yongjuan, et al.. (2013). The effects of situational factors and impulsiveness on drivers’ intentions to violate traffic rules: Difference of driving experience. Accident Analysis & Prevention. 62. 54–62. 35 indexed citations
20.
Li, Yongjuan, et al.. (2012). Pedestrians’ intention to jaywalk: Automatic or planned? A study based on a dual-process model in China. Accident Analysis & Prevention. 50. 811–819. 72 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026